Amin Tarang's Form 4/A amendment
Amendede.l.f. Beauty, Inc. (ELF) · filed Nov 10, 2025
- Accession no.
- 0001610717-25-000373
- Filed
- Nov 10, 2025
- Trade date
- Oct 1, 2025
- Filing delay
- 40 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Oct 3, 2025
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $15.4M. It was filed 40 days after the trade.
This amendment replaces 0001610717-25-000358 (filed Oct 3, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Amin TarangCIK 0001513988 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Common Stock, $0.01 par value | MOption exerciseAcquired | +194,537 | $17.00 | +$3,307,129 | 276,355 | Direct | |
| Oct 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −6,817 | $130.36F3 | −$888,664.12 | 269,538 | Direct | |
| Oct 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −33,038 | $131.86F4 | −$4,356,390.68 | 236,500 | Direct | |
| Oct 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −64,030 | $132.41F5 | −$8,478,212.3 | 172,470 | Direct | |
| Oct 1, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −12,430 | $133.44F6 | −$1,658,659.2 | 160,040 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Common Stock | MOption exerciseDisposed | −194,537 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025 and in connection with an exercise of stock options set to expire in September 2026. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise.
- F2
Includes 81,818 restricted stock units.
- F3
The transaction was executed in multiple trades in prices ranging from $130.05 to $130.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The transaction was executed in multiple trades in prices ranging from $131.07 to $132.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The transaction was executed in multiple trades in prices ranging from $132.07 to $133.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The transaction was executed in multiple trades in prices ranging from $133.07 to $134.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F7
The stock option is fully vested and exercisable.
Remarks
On October 3, 2025, the reporting person filed a Form 4 which inadvertently reported the wrong number of exercised shares.